Predictive and Prognostic Value of Metabolic Tumor Volume (MTV) in Patients with Laryngeal Carcinoma Treated by Radiotherapy (RT) / Concurrent Chemoradiotherapy (CCRT)
Fig 1
ROC curves for patients with locoregional control according to MTV (T, 2.5) status.
AUC 0.846 (95% CI 0.766–0.925, p < 0.001), cut off value 4.9 ml for MTV (T, 2.5) (n = 118). Sensitivity and specificity of the dichotomized MTV (T, 2.5) (≥ 4.9 vs < 4.9) were 0.759 and 0.831, respectively.